GlaxoSmithKline wins approval for bird flu vaccine
Date: 19 May 2008
GlaxoSmithKline has been granted EU approval for a new vaccine designed to combat the feared outbreak of a human-spread variant of the H5N1 bird influenza.
The company's Prepandrix will become the first vaccine for use in this eventuality, and various governments have already begun to stockpile the drug for the possible instance that the virus mutates from being a disease almost exclusively affecting birds to one that could be deadly to humans.
You must be logged in to add comments
In a recent article, the BBC's economics editor Robert Peston highlighted the fact that in 2012 the chances are that the economy - punch drunk as it is from the various flavours of debt crisis it has been pummelled with over the course of the year - will be hit by the collapse of a major bank and / or government.
Similar news stories
From the same country
Other stories about this company
Currently most popular stories